Quarterly report pursuant to Section 13 or 15(d)

Cash, Cash Equivalents and Marketable Securities

v3.22.2.2
Cash, Cash Equivalents and Marketable Securities
9 Months Ended
Sep. 30, 2022
Investments Debt And Equity Securities [Abstract]  
Cash, Cash Equivalents and Marketable Securities

5. Cash, Cash Equivalents and Marketable Securities

Cash equivalents are highly liquid investments that are readily convertible into cash with original maturities of three months or less when purchased. Marketable securities consist of securities with original maturities greater than 90 days when purchased. The Company classifies these marketable securities as available-for-sale and records them at fair value in the accompanying condensed consolidated balance sheets. Unrealized gains or losses are included in accumulated other comprehensive loss. Premiums or discounts from par value are amortized to interest income over the life of the underlying security.

Cash, cash equivalents and marketable securities consisted of the following at September 30, 2022 and December 31, 2021 (in thousands):

 

 

 

 

 

Unrealized

 

 

Unrealized

 

 

Fair

 

September 30, 2022

 

Amortized Cost

 

 

Gains

 

 

Losses

 

 

Value

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Cash and money market funds

 

$

170,122

 

 

$

 

 

$

 

 

$

170,122

 

Commercial paper

 

 

1,410

 

 

 

 

 

 

 

 

 

1,410

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities - due in one year or less

 

 

29,823

 

 

 

1

 

 

 

(138

)

 

 

29,686

 

Commercial paper

 

 

12,145

 

 

 

 

 

 

 

 

 

12,145

 

Municipal bonds

 

 

19,208

 

 

 

8

 

 

 

 

 

 

19,216

 

US Treasury obligation - due in one year or less

 

 

12,000

 

 

 

 

 

 

(98

)

 

 

11,902

 

Total

 

$

244,708

 

 

$

9

 

 

$

(236

)

 

$

244,481

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized

 

 

Unrealized

 

 

Fair

 

December 31, 2021

 

Amortized Cost

 

 

Gains

 

 

Losses

 

 

Value

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

Cash and money market funds

 

$

92,302

 

 

$

 

 

$

 

 

$

92,302

 

Marketable securities:

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities - due in one year or less

 

 

30,100

 

 

 

 

 

 

(12

)

 

 

30,088

 

US Treasury obligation - due in one year or less

 

 

8,000

 

 

 

 

 

 

(21

)

 

 

7,979

 

Corporate debt securities - due in more than one year to five years

 

 

9,085

 

 

 

 

 

 

(33

)

 

 

9,052

 

US Treasury obligation - due in more than one year to five years

 

 

3,999

 

 

 

 

 

 

(13

)

 

 

3,986

 

Total

 

$

143,486

 

 

$

 

 

$

(79

)

 

$

143,407

 

Although available to be sold to meet operating needs or otherwise, securities are generally held through maturity. The cost of securities sold is determined based on the specific identification method for purposes of recording realized gains and losses. During the nine months ended September 30, 2022 and 2021, there were no realized gains or losses on sales of investments, and no investments were adjusted for other-than-temporary declines in fair value.

As of September 30, 2022, marketable securities with maturities of one year or less when purchased are presented in current assets and those with maturities of more than one year are presented in the noncurrent assets in the accompanying condensed consolidated balance sheet.

At September 30, 2022, the Company held 50 securities that were in an unrealized loss position. The aggregate fair value of securities held by the Company in an unrealized loss position for less than 12 months as of September 30, 2022 was $33.1 million. There were seven securities held by the Company in an unrealized loss position for more than 12 months as of September 30, 2022. The Company has the intent and ability to hold such securities until recovery. The Company determined that there was no material change in the credit risk of the above marketable securities. As a result, the Company determined it did not hold any marketable securities with an other-than temporary impairment as of September 30, 2022.